Founded
Website
Recent investment activity
KANDO id: 114095
Company type
A biopharmaceutical company that discovers, develops and commercializes therapeutics.Funding rounds
N/A
( )
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Biotechnology Venture Fund | Initial investment. | ||
|
Venrock Associates | The venture capital arm of the Rockefeller Family. | Initial investment. |
| Investor | Profile | Country | |
|---|---|---|---|
|
Menlo Ventures | Bay Area venture capital firm that invests early stage across consumer, enterprise, and healthcare technologies. |
Actual initial investment stage
N/A (2)
Investment activity status
Active investor
Selected investments
Displaying 1 - 7 of 7| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
|
CGI Pharmaceuticals Inc | A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications. | Acquisition USD 120,000,000 (USD 120,000,000) | |||
|
|
Corus Pharma Inc | A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases. | Acquisition USD 365,000,000 (USD 365,000,000) | |||
|
|
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | Acquisition USD 464,000,000 (USD 464,000,000) | |||
|
|
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | |||
|
|
Achillion Pharmaceuticals Inc | Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease. | N/A Initial investment | |||
|
|
Arresto BioSciences Inc | A biotechnology company, develops medicines to treat cancer and fibrotic diseases | Acquisition USD 225,000,000 (USD 225,000,000) | |||
|
|
Calistoga Pharmaceuticals Inc | Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases. | Acquisition |